Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
2020 · Cells · 144 citations
https://doi.org/10.3390/cells9051287
D
Donatella Del Bufalo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
219
Papers
6.6K
Citations
49
h-index
115
i10-index
Donatella Del Bufalo is an academic researcher from National Cancer Institute. The author has contributed to research in topics: Protein Degradation and Inhibitors & Cell death mechanisms and regulation & Cancer, Hypoxia, and Metabolism. The author has an h-index of 49, co-authored 187 publications.
ORCID: 0000-0002-3148-6096Papers by this author
worksGrowth-Inhibitory and Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with or without BRAF Mutations
2009 · Neoplasia · 107 citations
https://doi.org/10.1593/neo.09398
Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells
2018 · Cell Death and Disease · 106 citations
https://doi.org/10.1038/s41419-018-1065-0
Toll-like Receptor 3 Regulates Angiogenesis and Apoptosis in Prostate Cancer Cell Lines through Hypoxia-Inducible Factor 1α
2010 · Neoplasia · 93 citations
https://doi.org/10.1593/neo.92106
microRNA-378a-5p iS a novel positive regulator of melanoma progression
2020 · Oncogenesis · 47 citations
https://doi.org/10.1038/s41389-020-0203-6
Removal of the BH4 Domain from Bcl-2 Protein Triggers an Autophagic Process that Impairs Tumor Growth
2013 · Neoplasia · 36 citations
https://doi.org/10.1593/neo.121392
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat